Patient safety is of utmost importance to ASPAR Pharmaceuticals.

Pharmacovigilance relates to the detection, assessment, understanding and prevention of the adverse effects or any other drug related problems.

While medicines have led to major improvement in the treatment and control of disease, all may cause side effects in some people.

Company Responsibilities

ASPAR Pharmaceuticals is responsible for the continued monitoring of the safety of their products. To manage these responsibilities companies must
fulfill a number of obligations including the collection and investigation of information relating to side-effects of their medicines, and reporting adverse
events to the regulatory authorities within strict timelines.

Information from spontaneous reports provided by health professionals and patients is of great value during the regular reviews of the safety profile of
ASPAR products, and enables the provision of a better service to health professionals and patients enquiring about side-effects and toxicity.